Houte Hans Van sold $116K of Nurix Therapeutics, Inc. (NRIX) stock

Houte Hans Van, Chief Financial Officer of Nurix Therapeutics, Inc. (NRIX), sold 4,761 shares of NRIX stock worth $116K, per an SEC Form 4 filed Aug 5, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 4, 2026, 1 day before it was made public.

NRIX has moved +2.9% since the trade date, from $24.69 to $25.41 (Sep 21, 2026 close).